- Home
- HSBC vs MRK Comparison
HSBC vs MRK Comparison
Compare HSBC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSBC
- MRK
- Stock Information
- Founded
- HSBC 1865
- MRK 2000
- Country
- HSBC United Kingdom
- MRK United States
- Employees
- HSBC N/A
- MRK N/A
- Industry
- HSBC Savings Institutions
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- HSBC Finance
- MRK Health Care
- Exchange
- HSBC Nasdaq
- MRK Nasdaq
- Market Cap
- HSBC 205.9B
- MRK 198.5B
- IPO Year
- HSBC N/A
- MRK N/A
- Fundamental
- Price
- HSBC $61.67
- MRK $83.30
- Analyst Decision
- HSBC Buy
- MRK Buy
- Analyst Count
- HSBC 1
- MRK 15
- Target Price
- HSBC N/A
- MRK $113.14
- AVG Volume (30 Days)
- HSBC 1.5M
- MRK 18.2M
- Earning Date
- HSBC 07-30-2025
- MRK 07-29-2025
- Dividend Yield
- HSBC 5.32%
- MRK 3.86%
- EPS Growth
- HSBC N/A
- MRK 667.14
- EPS
- HSBC 1.08
- MRK 6.88
- Revenue
- HSBC $57,994,000,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- HSBC $9.65
- MRK $2.42
- Revenue Next Year
- HSBC $1.20
- MRK $5.77
- P/E Ratio
- HSBC $10.86
- MRK $12.12
- Revenue Growth
- HSBC 2.38
- MRK 4.10
- 52 Week Low
- HSBC $39.42
- MRK $73.31
- 52 Week High
- HSBC $62.87
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- HSBC 59.20
- MRK 60.59
- Support Level
- HSBC $59.92
- MRK $80.15
- Resistance Level
- HSBC $62.87
- MRK $85.00
- Average True Range (ATR)
- HSBC 0.53
- MRK 1.84
- MACD
- HSBC 0.12
- MRK 0.37
- Stochastic Oscillator
- HSBC 74.63
- MRK 75.22
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in around 60 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.